These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 20569988)

  • 1. LFA-1 defect-induced effector/memory CD8+ T cell apoptosis is mediated via Bcl-2/Caspase pathways and associated with downregulation of CD27 and IL-15R.
    Ye Z; Shi M; Xu S; Xiang J
    Mol Immunol; 2010 Aug; 47(14):2411-21. PubMed ID: 20569988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
    Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
    J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pim kinase pathway contributes to survival signaling in primed CD8+ T cells upon CD27 costimulation.
    Peperzak V; Veraar EA; Keller AM; Xiao Y; Borst J
    J Immunol; 2010 Dec; 185(11):6670-8. PubMed ID: 21048108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets.
    Mortier E; Advincula R; Kim L; Chmura S; Barrera J; Reizis B; Malynn BA; Ma A
    Immunity; 2009 Nov; 31(5):811-22. PubMed ID: 19913445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo.
    Schluns KS; Kieper WC; Jameson SC; Lefrançois L
    Nat Immunol; 2000 Nov; 1(5):426-32. PubMed ID: 11062503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha tumor necrosis factor contributes to CD8(+) T cell survival in the transition phase.
    Shi M; Ye Z; Umeshappa KS; Moyana T; Xiang J
    Biochem Biophys Res Commun; 2007 Aug; 360(3):702-7. PubMed ID: 17618911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression.
    Matter MS; Claus C; Ochsenbein AF
    Eur J Immunol; 2008 Jul; 38(7):1847-56. PubMed ID: 18506879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.
    Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW
    Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death.
    Dai Z; Arakelov A; Wagener M; Konieczny BT; Lakkis FG
    J Immunol; 1999 Sep; 163(6):3131-7. PubMed ID: 10477579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo.
    Dolfi DV; Duttagupta PA; Boesteanu AC; Mueller YM; Oliai CH; Borowski AB; Katsikis PD
    J Immunol; 2011 Apr; 186(8):4599-608. PubMed ID: 21389258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation.
    Lee JB; Lee KA; Chang J
    Int Immunol; 2007 Sep; 19(9):1039-48. PubMed ID: 17823312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice.
    Bertolino P; Schrage A; Bowen DG; Klugewitz K; Ghani S; Eulenburg K; Holz L; Hogg N; McCaughan GW; Hamann A
    Hepatology; 2005 Nov; 42(5):1063-71. PubMed ID: 16250049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD27 is required for generation and long-term maintenance of T cell immunity.
    Hendriks J; Gravestein LA; Tesselaar K; van Lier RA; Schumacher TN; Borst J
    Nat Immunol; 2000 Nov; 1(5):433-40. PubMed ID: 11062504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8+ T cell memory.
    Scholer A; Hugues S; Boissonnas A; Fetler L; Amigorena S
    Immunity; 2008 Feb; 28(2):258-70. PubMed ID: 18275834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-redundant role for IL-7R signaling for the survival of CD8+ memory T cells.
    Carrio R; Rolle CE; Malek TR
    Eur J Immunol; 2007 Nov; 37(11):3078-88. PubMed ID: 17935075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for Bcl-6 in the generation and maintenance of memory CD8+ T cells.
    Ichii H; Sakamoto A; Hatano M; Okada S; Toyama H; Taki S; Arima M; Kuroda Y; Tokuhisa T
    Nat Immunol; 2002 Jun; 3(6):558-63. PubMed ID: 12021781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.